✦ LIBER ✦

Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer

✍ Scribed by Peter Kozuch; Steve Malamud; Carrie Wasserman; Peter Homel; Takhir Mirzoyev; Michael Grossbard

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of capecitabine, irinot

✍ Daniel J. Renouf; Stephen Welch; Malcolm J. Moore; Monika K. Krzyzanowska; Jenni 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 294 KB

A phase II trial of erlotinib in combina

✍ Do-Youn Oh, Keun Wook Lee, Kyung-Hee Lee, Chang-Hak Sohn, Young Suk Park, Dae Yo 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 224 KB

Bevacizumab plus capecitabine versus cap

✍ Cunningham, David; Lang, Istvan; Marcuello, Eugenio; Lorusso, Vito; Ocvirk, Janj 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 367 KB

Multicenter Phase II Study of Fixed Sequ

✍ Javier Cassinello; Jose Valero Álvarez; María José García López; Eduardo Pujol; 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 488 KB

Medical resource use in a phase III tria

✍ C. Twelves; E. Van Cutsem; K. Hieke; C. Barker; C. Jamieson; J. Hornberger; L. G 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 229 KB

A north central cancer treatment group P

✍ Henry C. Pitot; James A. Knost; Michelle R. Mahoney; John Kugler; James E. Krook 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 3 views